Diyabet ve Teknoloji
Özet
Diyabet, dünya genelinde ölümlerin ve organ kayıplarının önemli bir nedeni olan karmaşık ve kronik bir hastalıktır. Hastalığın yönetiminde ve komplikasyonların önlenmesinde kan glikoz düzeyinin kontrol altında tutulması kritik bir rol oynamakta, bu süreçte de bireylerin öz yönetim becerilerini geliştirmesi ve davranış değişikliği sağlaması gerekmektedir. Geleneksel olarak parmak ucundan kan alınarak yapılan izlemler ve standart insülin enjektörleri yerini, bilişim teknolojilerindeki hızlı gelişmeler sayesinde modern cihazlara bırakmıştır. Günümüzde diyabet yönetiminde; parmak delme zorunluluğunu azaltan sürekli glikoz izleme sistemleri (CGM), doz geçmişini kaydeden akıllı insülin kalemleri, sürekli insülin infüzyonu sağlayan insülin pompaları ve yapay pankreas işlevi gören hibrit kapalı devre sistemleri yaygın şekilde kullanılmaktadır. Ayrıca, hastaların uzaktan takibine imkan tanıyan tele-tıp uygulamaları ile ter, tükürük veya göz yaşından glikoz ölçümü yapabilen giyilebilir teknolojiler (akıllı lensler, glikoz-ter algılama cihazları ve hipoglisemi uyarı bileklikleri) ve mobil sağlık yazılımları hastaların yaşam kalitesini ve konforunu önemli ölçüde artırmaktadır. Bu teknolojik dönüşüm sürecinde hemşireler; eğitim, rehberlik, danışmanlık ve hastaların teknolojiye uyum sağlaması konularında anahtar bir rol üstlenmektedir. Diyabet teknolojileri, profesyonel hemşire takibi ve yapılandırılmış eğitim ile birleştiğinde metabolik kontrolü optimize ederek klinik sonuçları iyileştirmektedir.
Diabetes is a complex chronic disease that accounts for a significant portion of global mortality and morbidity, necessitating strict glycemic control to prevent debilitating complications and organ loss. Effective management relies heavily on patient self-management and permanent behavioral changes, areas where nursing interventions and education play a pivotal role in enhancing patient capabilities. Recent advancements in information technology have revolutionized diabetes care by introducing sophisticated devices and software that replace traditional self-monitoring methods. Modern diabetes management leverages Continuous Glucose Monitoring (CGM) systems for real-time tracking, smart insulin pens with dosing memory, continuous subcutaneous insulin infusion pumps, and hybrid closed-loop systems that automate basal insulin delivery. Furthermore, emerging tools such as telemedicine applications, mobile health diaries, and non-invasive wearable technologies—including glucose-sensing contact lenses, sweat or saliva analyzers, and hypoglycemia alert wristbands—significantly optimize glycemic control while lowering risks. Within this technological framework, nurses bear the vital responsibility of acquiring technical knowledge to guide, educate, and support patients through their adaptation processes. Ultimately, integrating advanced diabetes technology with consistent nursing follow-up and structured self-management education significantly alleviates the disease burden and improves the overall quality of life for individuals living with diabetes.
Referanslar
World Health Organization. Assessing national capacity for the prevention and control of noncommunicable diseases: report of the 2019 global survey. (04/06/2022 tarihinde https://www.who.int/publications/i/item/9789240002319 adresinden ulaşılmıştır).
Deyneli O, Yaşar M. İnsülin Kullanımında Yeni Teknolojiler: İnsülin Pompaları ve Glukoz Sensörleri. In: Satman İ, Akalın S, Yılmaz C, Salman S (ed). Geçmişten Geleceğe Diabetes Mellitus. Ankara: Pelin Ofset Matbaacılık;(2015). p. 274-279
Topçuoğlu GP, Avdal EÜA. Orem’in öz bakım eksikliği kuramına göre diyabet teknolojileri. Dokuz Eylül Üniversitesi Hemşirelik Fakültesi Elektronik Dergisi. 2021;14(3): 283-289. Doi:10.46483/deuhfed.865886
Besen BD, Dervişoğlu M. Diyabet yönetiminde teknoloji kullanımı. Turkiye Klinikleri Journal of Internal Medicine. 2021;6(2): 80-5. DOI: 10.5336/intermed.2020-77581
Barnard KD, Breton MD. Diabetes technological revolution: winners and losers?. Journal of Diabetes Science and Technology. 2018;12(6):1227-1230. https://doi.org/10.1177/1932296818788872
Canbolat Ö, Ekenler Ş, Polat Ü. Diyabet özyönetiminde engeller ve kolaylaştırıcılar. SDÜ Tıp Fakültesi Dergisi. 2022;29(1): 143-148. https://doi.org/10.17343/sdutfd.1008149
Hermanns N, Ehrmann D, Finke‐Groene K, et al. Trends in diabetes self‐management education: where are we coming from and where are we going? A narrative review. Diabetic Medicine. 2020;37(3): 436-447. https://doi.org/10.1111/dme.14256
American Diabetes Association. 1. Improving care and promoting health in populations: Standards of Medical Care in Diabetes. Diabetes care. USA: 2020. p. 77-89
Basit A, Khan A, Khan RA. BRIGHT guidelines on self-monitoring of blood glucose. Pakistan journal of medical sciences. 2014;30(5): 1150–1155. doi: http://dx.doi.org/10.12669/pjms.305.6006
Czupryniak L, Barkai L, Bolgarska S, et al. Self-monitoring of blood glucose in diabetes: from evidence to clinical reality in central and eastern europe- -recommendations from the international central-eastern european expert group. Diabetes technology & therapeutics. 2014; 16(7): 460-475. https://doi.org/10.1089/dia.2013.0302
Ginsberg BH. Factors affecting blood glucose monitoring: sources of errors in measurement. Journal of diabetes science and technology.2009:3(4);903-913. https://doi.org/10.1177/193229680900300438
Reznik Y. Handbook of diabetes technology. Springer. 2019
Reddy M, Jugnee N, El Laboudi A, et al. A randomized controlled pilot study of continuous glucose monitoring and flash glucose monitoring in people with type 1 diabetes and impaired awareness of hypoglycaemia. Diabetic Medicine. 2018;35: 483–490. https://doi.org/10.1111/dme.13561
Heinemann L, Freckmann G, Ehrmann D, et al. Real-time continuous glucose monitoring in adults with type 1 diabetes and impaired hypoglycaemia awareness or severe hypoglycaemia treated with multiple daily insulin injections (HypoDE): a multicentre, randomised controlled trial. Lancet. 2018;391: 1367–1377. http://dx.doi.org/10.1016/ S0140-6736(18)30297-6
Bolinder J, Antuna R, Geelhoed-Duijvestijn P, et al. Novel glucose-sensing technology and hypoglycaemia in type 1 diabetes: a multicentre, non-masked, randomised controlled trial. Lancet 2016;388:2254–2263.https://doi.org/10.1016/S0140-6736(16)31535-5
Pearson TL. Practical aspects of insulin pen devices. Journal of diabetes science and technology. 2010;4: 522–31. https://doi.org/10.1177%2F193229681000400304
Baruah MP. Insulin pens: the modern delivery devices. Journal of the Association of Physicians of India. 2011;59: 38-40.
Anderson BJ, Redondo MJ. What can we learn from patient-reported outcomes of insulin pen devices? Journal of diabetes science and technology. 2011;5:1563–71. https://doi.org/10.1177%2F193229681100500633
Timesulin, Timesulin announces successful FDA registration and partnership with Facet Technologies. 2014. (21/06/2022 tarihinde https://timesulin.com/timesulin-announces-successful-fda-registration-and-partnership-with-facet technologies/ adresinden ulaşılmıştır).
Bailey TS, Walsh J, Stone JY. Emerging technologies for diabetes care. Diabetes technology & therapeutics. 2018;20(S2); S2-78. https://doi.org/10.1089/dia.2018.0115
Danne T, Phillip M, Buckingham BA, et al. ISPAD Clinical Practice Consensus Guidelines 2018: Insulin treatment in children and adolescents with diabetes. Pediatric diabetes. 2018;19; 115-135. Doi: 10.1111/pedi.12718
Skyler JS, Ponder S, Kruger FD, et al. Is there a place for insulin pump therapy in your practice. Clinical Diabetes. 2007; 2: 50-56. https://doi.org/10.2337/diaclin.25.2.50
Yılmaz N, Doğruel H, Dalkıran Ş, et al. Erişkin tip 1 diabetes mellitus hastalarında insülin pompasının etkinliği. Akdeniz Tıp Dergisi. 2021;7(1): 111-118. Doi: 10.17954/amj.2021.3126
Kardaş GN, Gürol A. İnsülin kalemi ve pompası kullanan tip 1 diyabet hastası çocuklarda metabolik kontrol ve yaşam kalitesi düzeyleri. Kocaeli Üniversitesi Sağlık Bilimleri Dergisi. 2022;8(1); 65-71. https://doi.org/10.30934/kusbed.988288
Zabeen B, Craig ME, Virk SA, et al. (2016). Insulin pump therapy is associated with lower rates of retinopathy and peripheral nerve abnormality. PloS One. 2016;11(4); e0153033. https://doi.org/10.1371/journal.pone.0153033
Dos Santos TJ, Campos JDMD, Argente J, et al. Effectiveness and equity of continuous subcutaneous insulin infusions in pediatric type 1 diabetes: A systematic review and meta-analysis of the literature. Diabetes Research And Clinical Practice. 2021;172; 108643. https://doi.org/10.1016/j.diabres.2020.108643
Forlenza GP, Li Z, Buckingham BA, et al. Predictive low-glucose suspend reduces hypoglycemia in adults, adolescents,and children with type 1 diabetes in an at-home randomized crossover study: results of the PROLOG trial. Diabetes Care. 2018;41:2155–2161.https://doi.org/10.2337/dc18-0771
Evadıac. (04/06/2022 tarihinde www.evadiac.org Adresinden ulaşılmıştır).
Knebel T, Neumiller JJ. Medtronic MiniMed 670G hybrid closed-loop system. Clinical Diabetes. 2019; 37(1); 94-95. https://doi.org/10.2337/cd18-0067
Aleppo G, Webb KM. Integrated insulin pump and continuous glucose monitoring technology in diabetes care today: a perspective of real-life experience with the MiniMed™ 670G hybrid closed-loop system. Endocrine Practice. 2018;24(7): 684-692. https://doi.org/10.4158/EP-2018-0097
Ghosh S, Collier A. Inhaled insulins. Postgraduate Medical Journal. 2007;83(977); 178-181. http://dx.doi.org/10.1136/pgmj.2006.053868
Çetinkalp Ş, Yıldırım Ş. Yapay Pankreas: Bugünü ve Yarını. Klinik Tıp Bilimleri Dergisi. 2017;5(4): 58-59.
El-Khatib FH, Balliro C, Hillard MA, et al. Home use of a bihormonal bionic pancreas versus insulin pump therapy in adults with type 1 diabetes: a multicentre randomised crossover trial. The Lancet. 2017;389(10067):369-380. https://doi.org/10.1016/S0140-6736(16)32567-3
World Health Organization. Telemedicine: opportunities and developments in Member States: report on the second global survey on eHealth: Geneva, Switzerland World Health Organization, 2010 pp 93. (21/06/2022 tarihinde https://apps.who.int/iris/handle/10665/44497 adresinden ulaşılmıştır).
Dilbaz B, Kaplanoğlu M, Kaplanoğlu DK. Teletıp ve telesağlık: geçmiş, bugün ve gelecek. Eurasian Journal of Health Technology Assessment. 2020;4(1): 40-56.
Zhai YK, Zhu WJ, Cai YL, et al. Clinical-and cost-effectiveness of telemedicine in type 2 diabetes mellitus: a systematic review and meta-analysis. Medicine. 2014;93(28). http://dx.doi.org/10.1097/MD.0000000000000312
Sherr JL, Tauschmann M, Battelino T, et al. ISPAD Clinical Practice Consensus Guidelines 2018: Diabetes technologies. Pediatric diabetes. 2018;19, 302-325. Doi https://doi.org/10.1111/pedi.12731
Demirci Ş. Giyilebilir teknolojilerin sağlık hizmetlerine ve sağlık hizmet kullanıcılarına etkileri. Anemon Muş Alparslan Üniversitesi Sosyal Bilimler Dergisi. 2018; 6(6): 985-992.
Sağbaş EA, Ballı S, Yıldız T. Giyilebilir akıllı cihazlar: dünü, bugünü ve geleceği. Akademik Bilişim. 2016;749-756.
Hong YJ, Lee H, Kim J, et al. Blood sugar monitoring: Multifunctional wearable system that ıntegrates sweat-based sensing and vital-sign monitoring to estimate pre-/post-exercise glucose levels. Advanced Functional Materials. 2018;28: 1805754. https://doi.org/10.1002/adfm.201805754
Matchar E. This tiny tooth sensor could keep track of the food you eat. (04/06/2022 tarihinde https://www.smithsonianmag.com/innovation/this-tiny-tooth-sensor-could-keep-track-food-you-eat-180968763/ adresinden ulaşılmıştır).
Liu C, Sheng Y, Sun Y, et al. A glucose oxidase-coupled DNAzyme sensor for glucose detection in tears and saliva. Biosensors and Bioelectronics. 2015:70; 455-461. https://doi.org/10.1016/j.bios.2015.03.070
Lavars N. Google announces glucose-monitoring contact lens prototype. (04/06/2022 tarihinde https://newatlas.com/google-smart-contact-lens-diabetes/30494 adresinden ulaşılmıştır).
Hypoband. (04/06/2022 tarihinde https://www.hypoband.co.uk/pages/how-it-works adresinden ulaşılmıştır).
Årsand E, Muzny M, Bradway M, et al. Performance of the first combined smartwatch and smartphone diabetes diary application study. Journal of Diabetes Science and Technology. 2015;9: 556-563. Doi:10.1177/1932296814567708
